Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

457 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predicting the presence of depressive symptoms in the HIV-HCV co-infected population in Canada using supervised machine learning.
Marathe G, Moodie EEM, Brouillette MJ, Cox J, Cooper C, Delaunay CL, Conway B, Hull M, Martel-Laferrière V, Vachon ML, Walmsley S, Wong A, Klein MB; Canadian Co-Infection Cohort. Marathe G, et al. Among authors: klein mb. BMC Med Res Methodol. 2022 Aug 12;22(1):223. doi: 10.1186/s12874-022-01700-y. BMC Med Res Methodol. 2022. PMID: 35962372 Free PMC article.
CTN-194 (PICCO): design of a trial of citalopram for the prevention of depression and its consequences in HIV-hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapy.
Klein MB, Cooper C, Brouillette MJ, Sheehan NL, Benkelfat C, Annable L, Weston F, Kraus D, Singer J; CTN194 Investigators. Klein MB, et al. Contemp Clin Trials. 2008 Jul;29(4):617-30. doi: 10.1016/j.cct.2008.01.001. Epub 2008 Jan 12. Contemp Clin Trials. 2008. PMID: 18262853 Clinical Trial.
Cohort profile: the Canadian HIV-hepatitis C co-infection cohort study.
Klein MB, Saeed S, Yang H, Cohen J, Conway B, Cooper C, Côté P, Cox J, Gill J, Haase D, Haider S, Montaner J, Pick N, Rachlis A, Rouleau D, Sandre R, Tyndall M, Walmsley S. Klein MB, et al. Int J Epidemiol. 2010 Oct;39(5):1162-9. doi: 10.1093/ije/dyp297. Epub 2009 Sep 28. Int J Epidemiol. 2010. PMID: 19786463 No abstract available.
Cohort profile: the Canadian Observational Cohort collaboration.
Palmer AK, Klein MB, Raboud J, Cooper C, Hosein S, Loutfy M, Machouf N, Montaner J, Rourke SB, Smieja M, Tsoukas C, Yip B, Milan D, Hogg RS; CANOC Collaboration. Palmer AK, et al. Among authors: klein mb. Int J Epidemiol. 2011 Feb;40(1):25-32. doi: 10.1093/ije/dyp393. Epub 2010 Feb 15. Int J Epidemiol. 2011. PMID: 20157000 No abstract available.
Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries.
Raboud JM, Loutfy MR, Su D, Bayoumi AM, Klein MB, Cooper C, Machouf N, Rourke S, Walmsley S, Rachlis A, Harrigan PR, Smieja M, Tsoukas C, Montaner JS, Hogg RS; CANOC Collaboration. Raboud JM, et al. Among authors: klein mb. BMC Infect Dis. 2010 Feb 25;10:40. doi: 10.1186/1471-2334-10-40. BMC Infect Dis. 2010. PMID: 20184766 Free PMC article.
A CD4+ cell count <200 cells per cubic millimeter at 2 years after initiation of combination antiretroviral therapy is associated with increased mortality in HIV-infected individuals with viral suppression.
Loutfy MR, Genebat M, Moore D, Raboud J, Chan K, Antoniou T, Milan D, Shen A, Klein MB, Cooper C, Machouf N, Rourke SB, Rachlis A, Tsoukas C, Montaner JS, Walmsley SL, Smieja M, Bayoumi A, Mills E, Hogg RS; CANOC Collaboration. Loutfy MR, et al. Among authors: klein mb. J Acquir Immune Defic Syndr. 2010 Dec;55(4):451-9. doi: 10.1097/qai.0b013e3181ec28ff. J Acquir Immune Defic Syndr. 2010. PMID: 21105259
457 results